← Eichor
Study identifier: NCT06433349 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Multi-center Investigation of Family Health.

Condition: Breast Cancer · Prostate Cancer · Colorectal Cancer  ·  Sponsor: Odense University Hospital

PhaseN/A
Planned participants240
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The current healthcare system is unable to identify burdened and vulnerable families affected by cancer, partly due to a lack of knowledge of how cancer affects family health during treatment and survivorship. Recent reviews have documented a general lack of cancer studies including both the patient and the family, and a particular deficiency in studies including more than the spouse. The principal aim of this study is to investigate family health, needs and perceived support, quality of life, self-efficacy, depression, stress and resilience in both patients with cancer and their families across the cancer trajectory. Additionally, the study seeks to identify particularly burdened and vulnerable families and investigate contributing factors to their vulnerability.

This description comes directly from the study's public registry record.

Talk to the study team

Lærke K. Tolstrup, PhD  ·  +4540295129  ·  laerke.tolstrup@rsyd.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Odense University HospitalOdense C, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06433349